PMCBのPER（株価収益率）は？

PHARMACYTE BIOTECH INC（PMCB）は現在PER 119.93倍で取引されています。

PMCBのROE（自己資本利益率）は？

PHARMACYTE BIOTECH INCのROEは-1,376.50%です。

PMCBの配当利回りは？

PHARMACYTE BIOTECH INCの配当利回りは0.00%です。

PMCBの品質スコア（Quality Score）は？

当社のAIはPMCBの総合財務品質を100点中46点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

PMCBは今が買い時ですか？

当社AIのタイミングスコアは100点中0点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

PMCBはどのセクターに属しますか？

PHARMACYTE BIOTECH INCはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

PMCB (NASDAQ) 株価分析 | PHARMACYTE BIOTECH INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-04-30)

PMCB AI Analysis Summary

Our AI summary for PMCB: PHARMACYTE BIOTECH INC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 119.93, ROE of -1,376.50%, a dividend yield of 0.00%. Its financial Quality Score stands at 46/100 — fundamentals below the market average. The AI Timing Score is 0/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PMCB

PHARMACYTE BIOTECH INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 89

USD 0.58

-0.02 (-4.00%) Day Change

Watchlist Portfolio Compare Chart

119.93

P/E

6.98

D/E

-1,376.5%

ROE

-49.6%

ROA

0.00%

Div Yield

0.02

PEG

Data partially updated

PHARMACYTE BIOTECH INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.58 Price -0.02 (-4.00%) Day Change	NEWS SCORE: 89

PMCB, ファンダメンタルスコアはnot good ( ファンダメンタル = 46) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
平均ROEが低い
ROEが昨年度比で低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

52%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	89
Magic Formula Rank by ROA	1494
Magic Formula Rank by ROE	1494
Magic Formula Rank by ROIC	1632
Price	0.58
PBV / Sector	N/A / 5.20
Earning Per Share	-1,000,000.00

PE / Sector	119.93 / 19.97
PEG or PE/Growth / Sector	0.02 / 1.22 GREAT
Average 1M Daily Value	0.08 M GREAT
Average 1W Daily Value	0.13 M GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	N/A / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-49.64 / 27.02
ROA Average (%) / Sector	0.15 / -368.17
ROA Change Average (%) / Sector	3,191.54 / 5,404.12 GREAT
ROE (%) / Sector	-1,376.50 / 3.47
ROE Average (%) / Sector	-330.63 / 6.51
ROE Change Average (%) / Sector	1,450.02 / 2,128.13
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

登録情報

Analyze Date	2026-08-01 08:00:20
Symbol	PMCB
Name	PHARMACYTE BIOTECH INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	10.74 M
Par Value	N/A
Calculated From	YearEnd
Sign	N/A
Market Cap (M.USD) / Sector Average	1,498.75 / 9,903.94

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 3960 Howard Hughes Parkway, Las Vegas, NV, United States, 89169

Phone: 917 595 2850

Website: https://pharmacyte.com

Sector: Healthcare >> Biotechnology

Description: PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.